Back to Search Start Over

Neobladder and ablative pelvic radiotherapy: still a taboo?

Authors :
Bergamaschi L
Gerardi MA
Zaffaroni M
Augugliaro M
Vigorito S
Rondi E
Della Vigna P
Varano G
Fumagalli Romario U
Biffi R
Picardi EEE
Ferrari A
Jereczek-Fossa BA
Source :
Tumori [Tumori] 2021 Dec; Vol. 107 (6), pp. NP108-NP113. Date of Electronic Publication: 2021 Jul 08.
Publication Year :
2021

Abstract

The presence of a neobladder constitutes a limitation for the radiation oncologist, as there is no clear evidence about its tolerance to radiotherapy (RT). The limited literature only concerns the conventional postoperative treatment in patients with bladder cancer after cystectomy. Here we report a case of a patient with neobladder who underwent a stereotactic RT for a pelvic recurrence of disease, with response to treatment and no toxicity to the neobladder. This case represents a promising example of the chance to perform RT with ablative intent, using advanced techniques, even on lesions close to the neobladder.

Details

Language :
English
ISSN :
2038-2529
Volume :
107
Issue :
6
Database :
MEDLINE
Journal :
Tumori
Publication Type :
Academic Journal
Accession number :
34235994
Full Text :
https://doi.org/10.1177/03008916211031295